Literature DB >> 23343085

Opportunities and obstacles to screening pregnant women for intimate partner violence during antenatal care in Zimbabwe.

Simukai Shamu1, Naeemah Abrahams, Marleen Temmerman, Christina Zarowsky.   

Abstract

Pregnancy offers an opportunity for midwives to recognise and respond to women experiencing intimate partner violence (IPV). However, most antenatal care interventions have been conducted in private specialist services in high-income countries and do not address the structural and cultural realities of developing country settings. We report on an exploratory qualitative study conducted in antenatal public health facilities in Harare, Zimbabwe, involving six in-depth interviews with midwives and seven FGDs with 64 pregnant and postpartum women. Recorded interviews were transcribed verbatim and analysed using thematic content analysis. We found that identifying and responding to IPV in antenatal care is hampered by inadequate human, financial and infrastructural resources as well as poor support of gender-based violence training for midwives. Midwives had divergent views of their role, with some perceiving IPV as a non-clinical, social and domestic problem that does not require their attention, while others who had been sensitised to the problem felt that it could easily overwhelm them. A comprehensive response to IPV by midwives would be difficult to achieve in this setting but sensitised midwives could respond to cues to violence and ultimately assist abused women in culturally sensitive and appropriate ways.

Entities:  

Mesh:

Year:  2013        PMID: 23343085     DOI: 10.1080/13691058.2012.759393

Source DB:  PubMed          Journal:  Cult Health Sex        ISSN: 1369-1058


  8 in total

1.  Women's perceptions of how pregnancy influences the context of intimate partner violence in Germany.

Authors:  Heidi Stöckl; Frances Gardner
Journal:  Cult Health Sex       Date:  2013-08-01

2.  Bidirectional links between HIV and intimate partner violence in pregnancy: implications for prevention of mother-to-child transmission.

Authors:  Abigail M Hatcher; Nataly Woollett; Christina C Pallitto; Keneuoe Mokoatle; Heidi Stöckl; Catherine MacPhail; Sinead Delany-Moretlwe; Claudia García-Moreno
Journal:  J Int AIDS Soc       Date:  2014-11-03       Impact factor: 5.396

Review 3.  Screening, management, and treatment of intimate partner violence among women in low-resource settings.

Authors:  Laura M Schwab-Reese; Lynette M Renner
Journal:  Womens Health (Lond)       Date:  2018 Jan-Dec

4.  Facilitators and barriers to routine intimate partner violence screening in antenatal care settings in Uganda.

Authors:  Ronald Anguzu; Laura D Cassidy; Kirsten M M Beyer; Harriet M Babikako; Rebekah J Walker; Julia Dickson-Gomez
Journal:  BMC Health Serv Res       Date:  2022-03-02       Impact factor: 2.655

5.  Intimate partner violence, forced first sex and adverse pregnancy outcomes in a sample of Zimbabwean women accessing maternal and child health care.

Authors:  Simukai Shamu; Stephen Munjanja; Christina Zarowsky; Patience Shamu; Marleen Temmerman; Naeemah Abrahams
Journal:  BMC Public Health       Date:  2018-05-03       Impact factor: 3.295

6.  Ethiopian Health Care Workers' Insights into and Responses to Intimate Partner Violence in Pregnancy-A Qualitative Study.

Authors:  Bosena Tebeje Gashaw; Berit Schei; Kari Nyheim Solbraekke; Jeanette H Magnus
Journal:  Int J Environ Res Public Health       Date:  2020-05-25       Impact factor: 3.390

7.  Reactions to and explanations for the birth of a baby with albinism: a qualitative study in Busoga, Uganda.

Authors:  Julie Taylor; C Bradbury-Jones; Peter Ogik; Fazira Kawuma; Jane Betts; Patricia Lund
Journal:  BMJ Open       Date:  2021-02-23       Impact factor: 2.692

8.  Health practitioners' perceptions of structural barriers to the identification of intimate partner abuse: a qualitative meta-synthesis.

Authors:  Naomi Hudspeth; Jacqui Cameron; Surriya Baloch; Laura Tarzia; Kelsey Hegarty
Journal:  BMC Health Serv Res       Date:  2022-01-22       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.